These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

598 related items for PubMed ID: 23727083

  • 21. Statin/ezetimibe combination therapy vs statin monotherapy for carotid atherosclerotic plaque inflammation.
    Oh M, Kim H, Shin EW, Sung C, Kim DH, Moon DH, Lee JS, Lee PH, Lee SW, Lee CW.
    Medicine (Baltimore); 2021 Mar 12; 100(10):e25114. PubMed ID: 33725908
    [Abstract] [Full Text] [Related]

  • 22. Atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial.
    Kawahara T, Nishikawa M, Kawahara C, Inazu T, Sakai K, Suzuki G.
    Circulation; 2013 Jun 11; 127(23):2327-35. PubMed ID: 23658438
    [Abstract] [Full Text] [Related]

  • 23. Is it not timely to consider how to balance cardiorenometabolic benefits and risks of statins?
    Koh KK.
    J Am Coll Cardiol; 2014 Jul 01; 63(25 Pt A):2880-1. PubMed ID: 24794122
    [No Abstract] [Full Text] [Related]

  • 24. Reply: is it not timely to consider how to balance cardiorenometabolic benefits and risks of statins?
    Tawakol A, Emami H, Farkouh M, Fayad ZA, Fifer K, Rudd JH, Subramanian S, Van Dyke T.
    J Am Coll Cardiol; 2014 Jul 01; 63(25 Pt A):2881. PubMed ID: 24794123
    [No Abstract] [Full Text] [Related]

  • 25. Anti-inflammatory and morphologic effects of pitavastatin on carotid arteries and thoracic aorta evaluated by integrated backscatter trans-esophageal ultrasound and PET/CT: a prospective randomized comparative study with pravastatin (EPICENTRE study).
    Watanabe T, Kawasaki M, Tanaka R, Ono K, Kako N, Saeki M, Onishi N, Nagaya M, Sato N, Miwa H, Arai M, Noda T, Watanabe S, Minatoguchi S.
    Cardiovasc Ultrasound; 2015 Apr 02; 13():17. PubMed ID: 25889304
    [Abstract] [Full Text] [Related]

  • 26. Similar Impact of Clopidogrel or Ticagrelor on Carotid Atherosclerotic Plaque Inflammation.
    Oh M, Lee CW, Lee HS, Chang M, Ahn JM, Park DW, Kang SJ, Lee SW, Kim YH, Moon DH, Park SW, Park SJ.
    Clin Cardiol; 2016 Nov 02; 39(11):646-652. PubMed ID: 27459273
    [Abstract] [Full Text] [Related]

  • 27. Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.
    Millon A, Dickson SD, Klink A, Izquierdo-Garcia D, Bini J, Lancelot E, Ballet S, Robert P, Mateo de Castro J, Corot C, Fayad ZA.
    Atherosclerosis; 2013 Jun 02; 228(2):339-45. PubMed ID: 23582588
    [Abstract] [Full Text] [Related]

  • 28. Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [18F]FDG uptake in Ldlr-/-Apob100/100 mice.
    Hellberg S, Sippola S, Liljenbäck H, Virta J, Silvola JMU, Ståhle M, Savisto N, Metso J, Jauhiainen M, Saukko P, Ylä-Herttuala S, Nuutila P, Knuuti J, Roivainen A, Saraste A.
    Atherosclerosis; 2017 Aug 02; 263():369-376. PubMed ID: 28457625
    [Abstract] [Full Text] [Related]

  • 29. Comparison of fimasartan and amlodipine therapy on carotid atherosclerotic plaque inflammation.
    Oh M, Lee CW, Ahn JM, Park DW, Kang SJ, Lee SW, Kim YH, Moon DH, Park SW, Park SJ.
    Clin Cardiol; 2019 Feb 02; 42(2):241-246. PubMed ID: 30537083
    [Abstract] [Full Text] [Related]

  • 30. Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial.
    Lo J, Lu MT, Ihenachor EJ, Wei J, Looby SE, Fitch KV, Oh J, Zimmerman CO, Hwang J, Abbara S, Plutzky J, Robbins G, Tawakol A, Hoffmann U, Grinspoon SK.
    Lancet HIV; 2015 Feb 02; 2(2):e52-63. PubMed ID: 26424461
    [Abstract] [Full Text] [Related]

  • 31. Identification of inflamed atherosclerotic lesions in vivo using PET-CT.
    Jezovnik MK, Zidar N, Lezaic L, Gersak B, Poredos P.
    Inflammation; 2014 Apr 02; 37(2):426-34. PubMed ID: 24282108
    [Abstract] [Full Text] [Related]

  • 32. FDG-PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis.
    Davies JR, Izquierdo-Garcia D, Rudd JH, Figg N, Richards HK, Bird JL, Aigbirhio FI, Davenport AP, Weissberg PL, Fryer TD, Warburton EA.
    Int J Cardiovasc Imaging; 2010 Jan 02; 26(1):41-8. PubMed ID: 19784796
    [Abstract] [Full Text] [Related]

  • 33. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.
    Rudd JH, Myers KS, Bansilal S, Machac J, Pinto CA, Tong C, Rafique A, Hargeaves R, Farkouh M, Fuster V, Fayad ZA.
    J Nucl Med; 2008 Jun 02; 49(6):871-8. PubMed ID: 18483100
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
    Davidson MH, Rooney MW, Drucker J, Eugene Griffin H, Oosman S, Beckert M, LCP-AtorFen Investigators.
    Clin Ther; 2009 Dec 02; 31(12):2824-38. PubMed ID: 20110022
    [Abstract] [Full Text] [Related]

  • 35. Positron emission tomography measurement of periodontal 18F-fluorodeoxyglucose uptake is associated with histologically determined carotid plaque inflammation.
    Fifer KM, Qadir S, Subramanian S, Vijayakumar J, Figueroa AL, Truong QA, Hoffmann U, Brady TJ, Tawakol A.
    J Am Coll Cardiol; 2011 Feb 22; 57(8):971-6. PubMed ID: 21329844
    [Abstract] [Full Text] [Related]

  • 36. Delayed time-point 18F-FDG PET CT imaging enhances assessment of atherosclerotic plaque inflammation.
    Blomberg BA, Akers SR, Saboury B, Mehta NN, Cheng G, Torigian DA, Lim E, Del Bello C, Werner TJ, Alavi A.
    Nucl Med Commun; 2013 Sep 22; 34(9):860-7. PubMed ID: 23799532
    [Abstract] [Full Text] [Related]

  • 37. Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study.
    Niccoli Asabella A, Ciccone MM, Cortese F, Scicchitano P, Gesualdo M, Zito A, Di Palo A, Angiletta D, Regina G, Marzullo A, Rubini G.
    Ann Nucl Med; 2014 Jul 22; 28(6):571-9. PubMed ID: 24737136
    [Abstract] [Full Text] [Related]

  • 38. Biomechanical characteristics of isolated carotid atherosclerotic plaques assessed by ultrasonography.
    Li M, Li L, Wu W, Jiang Y, Zhang P.
    Int Angiol; 2019 Dec 22; 38(6):443-450. PubMed ID: 31782278
    [Abstract] [Full Text] [Related]

  • 39. Rosuvastatin effect on atherosclerotic plaque metabolism: A subclinical atherosclerosis imaging study with 18F-NaF PET-CT.
    Oliveira-Santos M, Borges-Rosa J, Silva R, Paixão L, Santo CE, Abrunhosa A, Castelo-Branco M, Slomka PJ, Gonçalves L, Ferreira MJ.
    Atherosclerosis; 2024 Aug 22; 395():117481. PubMed ID: 38480058
    [Abstract] [Full Text] [Related]

  • 40. Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.
    Hong YJ, Jeong MH, Hachinohe D, Ahmed K, Choi YH, Cho SH, Hwang SH, Ko JS, Lee MG, Park KH, Sim DS, Yoon NS, Yoon HJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC.
    Circ J; 2011 Aug 22; 75(2):398-406. PubMed ID: 21157106
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.